Eli Lilly (LLY) shares outstanding: 940.7M
Eli Lilly had 940.7M shares outstanding on Oct 26, 2026, down 0.5% from 945.4M a year earlier.
From Eli Lilly's filings with the SEC · LLY stock page
Eli Lilly shares outstanding by year
#118 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 26, 2026 | 940.7M | -0% |
| Oct 27, 2025 | 945.4M | -0% |
| Oct 25, 2024 | 949.3M | No change |
| Oct 30, 2023 | 949.3M | -0% |
| Oct 28, 2022 | 950.2M | – |
Shares outstanding of similar companies
Companies in the same industry as Eli Lilly, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| TEVA Pharmaceutical Industries | 1.17B | Sep 30, 2026 |
| Viatris | 1.15B | Nov 2, 2026 |
| Eli Lilly | 940.7M | Oct 26, 2026 |
| HUTCHMED (China) | 872.3M | Dec 31, 2025 |
| Summit Therapeutics | 799.8M | Oct 30, 2026 |
| Opko Health | 742.5M | Oct 20, 2026 |
| Roivant Sciences | 724.6M | Nov 3, 2026 |
Questions and answers
What is Eli Lilly's shares outstanding?
Eli Lilly had 940.7M shares outstanding on Oct 26, 2026, down 0.5% from 945.4M a year earlier.
Numbers as reported in Eli Lilly's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology